Finemox CV XR gives extended effect over long period of time. Amoxicillin is beta-lactam antibiotic, supported by Clavulanic acid which enhances its action and provides anti-bacterial solution to various needs. It is indicated in Urinary tract infections, Acute uncomplicated cystitis, Chronic bacterial prostatitis, Lower respiratory tract infections, Acute sinusitis, Skin and Skin structure infections, Bone and Joint infections.
This combination is one of the most preferred one among doctors. Amoxicillin is beta-lactam antibiotic, acts by inhibiting cell wall synthesis and Clavulanic acid is an irreversible inhibitor of beta lactamase enzyme. It is indicated in Urinary tract infections, Acute uncomplicated cystitis, Chronic bacterial prostatitis, Lower respiratory tract infections, Acute sinusitis, Skin and Skin structure infections, Bone and Joint infections
This combination is one of the most preferred one among doctors. Amoxicillin is beta-lactam antibiotic, supported by Clavulanic acid which protects Amoxicillin from degradation by Beta-Lactamases producing strains. Finemox CV is indicated in Urinary tract infections, Acute uncomplicated cystitis, Chronic bacterial prostatitis, Lower respiratory tract infections, Acute sinusitis, Skin and Skin structure infections, Bone and Joint infections.
Finemox CV syrup is combination of Amoxicillin and Clavulanic acid. Amoxicillin is beta-lactam antibiotic, acts by inhibiting cell wall synthesis. Amoxicillin is susceptible to degradation by β-lactamases. The clavulanic acid protects amoxicillin from degradation by β-lactamase enzymes and effectively extends the antibiotic spectrum of amoxicillin to include many bacteria normally resistant to amoxicillin and other β-lactam antibiotics. It is indicated in Urinary tract infections, Acute uncomplicated cystitis, Chronic bacterial prostatitis, Lower respiratory tract infections, Acute sinusitis, Skin and Skin structure infections, Bone and Joint infections
Cefine CV is a combination of Cefixime and Clavulanic Acid. Cefixime belongs to third generation cephalosporin antibiotics and acts by inhibiting cell wall synthesis. Clavulanic acid is an irreversible inhibitor of beta lactamase enzyme. When this combination is used, it allows Cefixime to work as a bacteriocidal and enhances its activity. It is indicated in Urinary Tract Infections, Acute Otitis Media and also in Respiratory Infections
Cefine CV is combination of Cefixime and Clavulanic Acid. Cefixime belongs to third generation cephalosporin antibiotics which act by inhibiting cell wall synthesis. Clavulanic acid is an irreversible inhibitor of beta lactamase enzyme. This combination allows cefixime to work as a bacteriocidal protects degradation by beta lactamases. It is indicated in Urinary Tract Infections, Acute Otitis Media and also in Respiratory Infections including various bacterial infections.
Cefine CV 100 is combination of Cefixime and Clavulanic Acid. Cefixime belongs to third generation cephalosporin antibiotics acts by inhibiting cell wall synthesis. Clavulanic acid is an irreversible inhibitor of beta lactamase enzyme and has mild antibiotic activity. when this combination is used, it allow cefixime to work as a bacteriocidal and enhances its activity. It is indicated in Urinary Tract Infections, Acute Otitis Media and also in Respiratory Infections
Cefine CV is combination of Cefixime and Clavulanic Acid. Cefixime belongs to third generation cephalosporin antibiotics, acts by inhibiting cell wall synthesis. Clavulanic acid is an irreversible inhibitor of beta lactamase enzyme and has mild antibiotic activity. This combination allows cefixime to work as a bacteriocidal with enhanced activity. It is indicated in various bacterial infections.
Cefpo CV contains Cefpodoxime which is third generation cephalosporin, exhibits activity against several Gram positive as well as Gram negative microorganisms and Clavulanic acid which is a natural inhibitor of beta lactamase. It restricts Cefpodoxime destruction. It is indicated in Community Acquired Pneumonia, Uncomplicated Skin and Skin Structure Infections and Uncomplicated Urinary Tract Infections. Cefpo CV 50 Oral Suspension is dosage form for pediatric use.
In combination, Cefpodoxime is third generation cephalosporin antibiotics acts by inhibiting cell wall synthesis. Clavulanic acid is an irreversible inhibitor of beta lactamase enzyme and has mild antibiotic activity. When this combination is used, it allow Cefpodoxime to work as a bacteriocidal and enhances its activity. It is indicated in Community Acquired Pneumonia, Uncomplicated Skin and Skin Structure Infections and Uncomplicated Urinary Tract Infections.
Cefpodoxime, a third generation cephalosporin, exhibits activity against several Gram positive as well as Gram negative microorganisms. Clavulanic acid is a natural inhibitor of beta lactamase. It restricts cefpodoxime destruction. It is indicated in Community Acquired Pneumonia, Uncomplicated Skin and Skin Structure Infections and Uncomplicated Urinary Tract Infections.
Cefpodoxime, a third generation cephalosporin, exhibits activity against several Gram positive as well as Gram negative microorganisms. Clavulanic acid is a natural inhibitor of beta lactamase. It restricts cefpodoxime destruction. It is indicated Acute bacterial exacerbations of chronic bronchitis, Acute community acquired Pneumonia, Upper and lower respiratory tract infections, Skin and soft tissue infections, Urinary tract infections, Pharyngitis, General gonorrhea (men and women) and Rectal gonococcal infections (women), Acute maxillary sinusitis.
Sayfur CV contains combination of Cefuroxime and Clavulanic acid. Cefuroxime is second generation antibiotic which acts by inhibiting protein synthesis. Clavulanic acid is an irreversible inhibitor of beta lactamase enzyme. Thus have wide range of activity. It is indicated in infections caused by staphylococci, H.influenzae, E.coli, Salmonella, Urinary tract infections, Early lime disease.
Sayfur CV contains combination of Cefuroxime and Clavulanic acid. Cefuroxime is second generation antibiotic which acts by inhibiting protein synthesis. Clavulanic acid is an irreversible inhibitor of beta lactamase enzyme. Thus have wide range of activity. It is indicated in infections caused by staphylococci, H.influenzae, E.coli, Salmonella, Urinary tract infections, Early lime disease.
Sayfur CV 500 is a combination of Cefuroxime and ß -lactamase inhibitor (Clavulanic acid) for the treatment of various bacterial infections and is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions as Pharyngitis/tonsillitis, Acute bacterial Otitis media, Acute bacterial maxillary sinusitis, Acute bacterial exacerbations of chronic bronchitis and secondary bacterial infections of acute bronchitis, Uncomplicated skin and skin-structure infections, Uncomplicated urinary tract infections, Uncomplicated gonorrhea (urethral and endocervical) and Early lyme disease.
Sayfur CV contains combination of Cefuroxime and Clavulanic acid. Cefuroxime is second generation antibiotic which acts by inhibiting protein synthesis. And clavulanic acid is an irreversible inhibitor of beta lactamase enzyme. Thus have wide range of activity. It is indicated in infections caused by various organisms as staphylococci, H.influenzae, E.coli, Salmonella, Urinary tract infections, Early lime disease.
PT 4.5 is combination antibiotic which contains Penicillin antibiotic Piperacillin and Tazobactam which is beta-lactamases inhibitor. It is indicated in severe infections caused by Piperacillin-resistant organism, Community acquired pneumonia, Pelvic inflammatory disease, Uncomplicated and Complicated skin and skin structure infections, Postpartum Endometritis, Nosocomial pneumonia.
Finetriax-S Kid is a combination of Ceftriaxone and Sulbactum. Ceftriaxone belong to third generation cephalosporin antibiotic. Sulbactam acts as beta-lactamase inhibitor, thus restoring Ceftriaxone activity against beta-lactamase producing strains. Thus inhibits bacterial cell growth. It is indicated in Urinary tract infections, Lower respiratory tract infections, Acute sinusitis, Skin and skin structure infections, Bone and Joint infections, Intra-abdominal infections and Meningitis. Finetriax-S kid is designed for pediatric use.
Finetriax-S brand contains Ceftriaxone. It belong to third generation Cephalosporin antibiotic. Sulbactam acts as beta-lactamase inhibitor, thus restoring Ceftriaxone activity against beta-lactamase producing strains. Thus inhibits bacterial cell growth. It is indicated in Urinary tract infections, Lower respiratory tract infections, Acute sinusitis, Skin and skin structure infections, Bone and Joint infections, Intra-abdominal infections and Meningitis.
Finetriax-T is combination of Ceftriaxone (3rd generation cephalosporin) and Tazobactam (betalactamase inhibitor). It is used for treatment of bacterial infections caused beta lactam resistant pathogens. It is indicated in Urinary tract infections, Lower respiratory tract infections, Acute sinusitis, Skin and skin structure infections, Bone and Joint infections, Intra-abdominal infections and Meningitis.
Finetriax-T 500 contains combination of Ceftriaxone and Tazobactum. This combination exhibits a synergy that is not influenced by the presence or absence of oxygen. In addition, this synergy remains excellent at neutral pH. Finetriax-T has excellent anti-bacterial activity. It is indicated in Urinary tract infections, Lower respiratory tract infections, Acute sinusitis, Skin and skin structure infections, Bone and Joint infections, Intra-abdominal infections and Meningitis.
Finetriax-T 1000 is the combination of Ceftriaxone and Tazobactum. Ceftriaxone has a broad spectrum of antibacterial activity. By rendering β–lactamase inactive, Tazobactam protect the activity of Cephalosporin antibiotics. It is indicated in Urinary tract infections, Lower respiratory tract infections, Acute sinusitis, Skin and skin structure infections and Bone and Joint infections.
Cefosal contains Cefoperazone and Sulbactum. Cefoperazone, a third generation Cephalosporin antibiotic acts by inhibiting biosynthesis of cell wall mucopeptide. Sulbactam acts as beta-lactamase inhibitor, thus restoring Cefoperazone activity against beta-lactamase producing strains. Combination is indicated in Respiratory Tract Infections (Upper and Lower), Urinary Tract Infections (Upper and Lower), Peritonitis, Cholecystitis, Cholangitis and Other Intra-Abdominal Infections, Septicemia, Meningitis, Skin and Soft Tissue Infections
